From Cryoprecipitate to Virus-Safe High-Purity Concentrate

Norbert Heimburger

doi:10.1055/s-2002-30192

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2002; 28(S1): 025-030
DOI: 10.1055/s-2002-30192

From Cryoprecipitate to Virus-Safe High-Purity Concentrate

Norbert Heimburger

Department of Hemostasology at Behringwerke A.G., Marburg, Germany

Abstract

Volltext

Referenzen

REFERENCES

1 Austen D EG. The chromatographic separation of F VIII on aminohexyl sepharose. Br J Haematol . 1979; 43 669-674
2 Pool J G, Hershgold E J, Pappenhagen A R. High potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature . 1984; 203 312
3 Schimpf K, Zimmermann K, Thamer G, Ruedel J. Frequency of hepatitis B surface antigen antibody in patients of the Heidelberg Hemodialysis Center. Verh Dtsch Ges Inn Med . 1976; 82(Part 1) 414-417
4 Heimburger N, Schwinn H, Gratz P. A factor VIII concentrate, highly purified and heated in solution. 1st International Haemophilia Conference, Bonn, October 3-7, 1980. Hemostasis (Abst) . 1981; 204(Suppl 1) 110
5 Heimburger N, Schwinn H, Gratz P. Faktor VIII-Konzentrat, hochgereinigt und in Lösung erhitzt. Arzneimittelforschung . 1981; 31 619-622
6 Mösseler J, Schimpf K, Auerswald G. Inability of pasteurized factor VIII preparations to induce antibodies to HTLV-III after long-term treatment. Lancet . 1985; 1 111
7 Schimpf K, Mannucci P M, Kreuz W. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion. N Engl J Med . 1987; 316 918-922
8 Schimpf K, Brackmann H H, Kreuz W. Absence of antihuman immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate. N Engl J Med . 1989; 321 1148-1152
9 Kreuz W, Auerswald G, Bruckmann C. Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease. Thromb Haemost (Letter) . 1992; 67 184
10 Concerning more detailed literature see the monograph ``Virus Inactivation in Plasma Products'' (Morgenthaler J-J, ed.) which appeared as Current Studies in Hematology and Blood Transfusion, Vol. 56. (Hässig A, Lundsgaard-Hansen P, eds. Basil: Karger-Verlag; 1989)